Dhanuka Agritech Limited

BSE:507717 Aktierapport

Börsvärde: ₹52.8b

Dhanuka Agritech Framtida tillväxt

Future kriterier kontrolleras 2/6

Dhanuka Agritech förväntas öka intäkter och intäkter med 10.5% respektive 11% per år. EPS förväntas tillväxt med 10.9% per år. Avkastningen på eget kapital förväntas bli 16.5% om 3 år.

Viktig information

10.5%

Tillväxttakt i vinsten

10.85%

Tillväxttakt för EPS

Chemicals vinsttillväxt19.4%
Intäkternas tillväxttakt11.0%
Framtida avkastning på eget kapital16.45%
Bevakning av analytiker

Good

Senast uppdaterad22 May 2026

Senaste uppdateringarna om framtida tillväxt

Recent updates

Uppdatering av berättelse • May 03

507717: Upcoming Director Appointment Will Support Future Upside Confidence

Analysts have nudged their price target on Dhanuka Agritech slightly higher, with fair value moving from ₹1,426.00 to about ₹1,439.57, citing updated assumptions around the discount rate, revenue growth, profit margins and future P/E. What's in the News A postal ballot based Special or Extraordinary Shareholders Meeting is scheduled for March 19, 2026, in India (Key Developments).
Uppdatering av berättelse • Apr 18

507717: Upcoming Governance And Earnings Dates Will Support Future Upside Confidence

Analysts have trimmed their price target on Dhanuka Agritech slightly from ₹1,438.50 to ₹1,426.00, reflecting updated assumptions around the discount rate, revenue growth, profit margin, and forward P/E. What's in the News Special or Extraordinary Shareholders Meeting scheduled via postal ballot in India on Mar 19, 2026, to consider appointing Mr. Sanjiv Goel (DIN: 03616090) as an Independent Director for a first term of 5 years (company filing).
Uppdatering av berättelse • Apr 03

507717: Upcoming Governance And Earnings Dates Will Support Upside Confidence

Analysts have kept their price target for Dhanuka Agritech steady at around ₹1,438, reflecting largely unchanged views on fair value, discount rate, revenue growth, profit margin and future P/E assumptions. What's in the News Dhanuka Agritech has scheduled a Special or Extraordinary Shareholders Meeting via postal ballot in India on March 19, 2026, to consider appointing Mr. Sanjiv Goel (DIN: 03616090) as an Independent Director for a first term of 5 years (Key Developments).
Uppdatering av berättelse • Mar 19

507717: Upcoming Meetings Will Reinforce Confidence In Sustained Upside Potential

Analysts have kept the price target for Dhanuka Agritech broadly steady at around ₹1,438, with only minor model tweaks to the discount rate and the assumed future P/E driving the small change. What's in the News A Special or Extraordinary shareholders meeting is scheduled via postal ballot in India on Mar 19, 2026, to consider appointing Mr. Sanjiv Goel (DIN: 03616090) as an independent director for a first term of 5 years (company filing).
Uppdatering av berättelse • Mar 05

507717: Upcoming Meetings Will Support Confidence In Long-Term Upside Potential

Analysts have maintained their ₹1,438.50 price target for Dhanuka Agritech and made only minor adjustments to their assumptions on discount rate, revenue growth, profit margin and future P/E. These limited changes suggest that their overall valuation framework remains broadly consistent with earlier assessments.
Ny berättelse • Feb 21

Rural Distribution And Biostimulant Tailwinds Will Support A Stronger Long Term Outlook

Catalysts About Dhanuka Agritech Dhanuka Agritech is an Indian agrochemical company supplying crop protection and allied products to farmers across major agricultural regions in India. What are the underlying business or industry changes driving this perspective?
Uppdatering av berättelse • Feb 19

507717: Upcoming Board And Shareholder Meetings Will Support Long-Term Upside Potential

Analysts have revised their price target on Dhanuka Agritech from ₹1,571.75 to ₹1,438.50, reflecting updated assumptions around the discount rate, expected revenue growth, profit margin and future P/E multiples. What's in the News Dhanuka Agritech has scheduled a Board Meeting on Feb 05, 2026, at 13:00 Indian Standard Time to consider and approve the financial results for the quarter and nine months ended Dec 31, 2025 (Key Developments).
Ny berättelse • Feb 06

Dahej Ramp Up Risks And Regulatory Setbacks Will Eventually Support A Stronger Business

Catalysts About Dhanuka Agritech Dhanuka Agritech is an Indian agrochemical company supplying crop protection products and related offerings to farmers across major agricultural regions. What are the underlying business or industry changes driving this perspective?
Uppdatering av berättelse • Feb 04

507717: Stable Assumptions And Upcoming Results Will Support Long-Term Upside Potential

Analysts have kept their price target for Dhanuka Agritech unchanged at ₹1,571.75, citing broadly consistent assumptions for the discount rate, revenue growth, profit margin and future P/E in their refreshed model. What's in the News Dhanuka Agritech has scheduled a board meeting on Feb 05, 2026.
Uppdatering av berättelse • Jan 21

507717: Higher Margin Outlook Will Support Long-Term Upside Potential

Analysts have trimmed their price target for Dhanuka Agritech by ₹35 to ₹1,571.75. This reflects updated views on slightly lower revenue growth assumptions, a modestly higher discount rate, and a small adjustment to future P/E expectations, partly offset by a marginally higher profit margin outlook.
Uppdatering av berättelse • Jan 06

507717: Nagpur Plant Land Purchase Will Support Long-Term Upside Potential

Analysts have kept their price target for Dhanuka Agritech unchanged at ₹1,606.75, with only minor tweaks to inputs such as the discount rate, revenue growth, profit margin, and future P/E assumptions guiding their view. What's in the News Board meeting scheduled on Oct 31, 2025 at 11:00 Indian Standard Time to review and approve financial results for the quarter and half year ended Sep 30, 2025 (company filing).
Uppdatering av berättelse • Dec 16

507717: Nagpur Formulation Plant Expansion Will Drive Long-Term Upside Potential

Analysts have nudged their fair value estimate for Dhanuka Agritech down slightly from ₹1,638 to about ₹1,607 per share, reflecting tempered revenue growth expectations, partially offset by a modestly higher projected profit margin and a slightly lower assumed future P E multiple. What's in the News Board meeting scheduled on October 31, 2025, at 11:00 IST to review financial results for the quarter and half year ended September 30, 2025 (company filing) Board to consider purchase of land in Nagpur, Maharashtra, for setting up a new formulation plant, indicating planned capacity expansion (company filing) Outcome of the October 31, 2025 board meeting expected to provide clarity on near term growth, capex, and margin trajectory (company filing) Valuation Changes The fair value estimate was reduced slightly from ₹1,638 to about ₹1,607 per share, reflecting marginally softer assumptions.
Uppdatering av berättelse • Dec 02

507717: Upcoming Nagpur Plant And Board Actions Will Fuel Long-Term Momentum

Analysts have maintained their fair value estimate for Dhanuka Agritech at ₹1,638, citing stable projections for growth and profitability despite minor adjustments in underlying assumptions. What's in the News Dhanuka Agritech will hold a Board Meeting on October 31, 2025, at 11:00 Indian Standard Time (Board Meeting announcement).
Uppdatering av berättelse • Nov 17

507717: New Formulation Plant Decision Will Drive Next Wave Of Expansion

Analysts have lowered their price target for Dhanuka Agritech from ₹1,779.88 to ₹1,638.00. This reflects tempered expectations for future revenue growth and profit margins.
Uppdatering av berättelse • Nov 03

507717: New Nagpur Plant And Higher Margins Will Drive Future Upside

Analysts have revised their price target for Dhanuka Agritech downward from ₹1,875 to ₹1,779.88. This adjustment reflects updated projections in revenue growth and profit margins, as well as a slightly reduced future valuation multiple.
Uppdatering av berättelse • Sep 05

Improved Monsoon Trends And Capacity Expansion Will Drive Agrochemicals Demand

With both the discount rate and future P/E essentially unchanged, analysts maintained Dhanuka Agritech’s fair value at ₹1875. What's in the News Board meeting scheduled to consider and approve financial results for the quarter ended 30 June, 2025.
User avatar
Ny berättelse • Feb 09

Acquiring Rights To Iprovalicarb And Triadimenol Will Open International Markets

International expansion and product innovation could boost revenue through new market entry, geographic diversification, and premium pricing for unique solutions.

Prognoser för vinst- och omsättningstillväxt

BSE:507717 - Analytikernas framtida uppskattningar och tidigare finansiella data (INR Millions )
DatumIntäkterIntäkterFritt kassaflödeKassaflöde från rörelsenGenomsnittligt Antal analytiker
3/31/202928,374N/AN/AN/A1
3/31/202826,1023,5382,5333,1726
3/31/202722,9723,0651,9692,7525
3/31/202620,6282,8721,6851,962N/A
12/31/202519,7852,650N/AN/AN/A
9/30/202520,1382,8007142,663N/A
6/30/202520,6993,036N/AN/AN/A
3/31/202520,3522,9706872,627N/A
12/31/202419,6142,805N/AN/AN/A
9/30/202419,1942,7089851,431N/A
6/30/202418,8312,550N/AN/AN/A
3/31/202417,5852,3914511,345N/A
12/31/202317,6152,454N/AN/AN/A
9/30/202317,5162,4611,0612,317N/A
6/30/202316,7662,173N/AN/AN/A
3/31/202317,0022,3351201,362N/A
12/31/202216,4732,226N/AN/AN/A
9/30/202216,1082,191-640331N/A
6/30/202215,0672,094N/AN/AN/A
3/31/202214,7782,0894451,043N/A
12/31/202114,3502,031N/AN/AN/A
9/30/202113,7382,0077921,038N/A
6/30/202113,7742,074N/AN/AN/A
3/31/202113,8752,1062,1842,311N/A
12/31/202013,3952,009N/AN/AN/A
9/30/202013,1531,8862,5892,726N/A
6/30/202012,7491,785N/AN/AN/A
3/31/202011,2011,4131,4841,621N/A
12/31/201910,8521,291N/AN/AN/A
9/30/201910,3051,160N/A627N/A
6/30/201910,1181,111N/AN/AN/A
3/31/201910,0581,126N/A133N/A
12/31/20189,9821,145N/AN/AN/A
9/30/201810,0291,285N/AN/AN/A
6/30/20189,6761,262N/AN/AN/A
3/31/20189,6261,262N/A1,377N/A
12/31/20179,2651,201N/AN/AN/A
9/30/20179,1681,183N/AN/AN/A
6/30/20178,8121,156N/AN/AN/A
3/31/20178,8331,219N/A631N/A
12/31/20168,8861,237N/AN/AN/A
9/30/20168,8571,196N/AN/AN/A
6/30/20168,4691,081N/AN/AN/A
3/31/20168,2891,073N/A1,397N/A
12/31/20158,1161,007N/AN/AN/A
9/30/20157,8501,002N/AN/AN/A
6/30/20157,9771,042N/AN/AN/A

Analytiker Framtid Tillväxt Prognoser

Intäkter kontra sparande: 507717 s prognostiserade vinsttillväxt ( 10.5% per år) är över sparkvoten ( 6.9% ).

Resultat vs marknad: 507717 s intäkter ( 10.5% per år) förväntas växa långsammare än marknaden för Indian ( 16.3% per år).

Höga tillväxtresultat: 507717 s intäkter förväntas växa, men inte avsevärt.

Intäkt vs marknad: 507717 s intäkter ( 11% per år) förväntas växa snabbare än Indian marknaden ( 10.8% per år).

Hög tillväxtintäkter: 507717 s intäkter ( 11% per år) förväntas växa långsammare än 20% per år.

Tillväxtprognoser för vinst per aktie

Framtida avkastning på eget kapital

Framtida ROE: 507717 s avkastning på eget kapital förväntas bli låg om 3 år ( 16.5 %).

Upptäck tillväxtföretag

7D

1Y

7D

1Y

7D

1Y

Företagsanalys och finansiella data Status

UppgifterSenast uppdaterad (UTC-tid)
Analys av företag2026/05/22 11:29
Aktiekurs vid dagens slut2026/05/22 00:00
Intäkter2026/03/31
Årlig intjäning2026/03/31

Datakällor

Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.

PaketUppgifterTidsramExempel US-källa
Företagets finansiella ställning10 år
  • Resultaträkning
  • Kassaflödesanalys
  • Balansräkning
Analytikernas konsensusuppskattningar+3 år
  • Prognos för finansiella poster
  • Analytikernas prismål
Marknadspriser30 år
  • Aktiekurser
  • Utdelningar, splittar och åtgärder
Ägarskap10 år
  • Största aktieägare
  • Insiderhandel
Förvaltning10 år
  • Ledningsgrupp
  • Styrelse och verkställande direktörer
Viktiga utvecklingstendenser10 år
  • Företagsmeddelanden

* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.

Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.

Analysmodell och snöflinga

Detaljer om analysmodellen som användes för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och tutorials på Youtube.

Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.

Industri- och sektormått

Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.

Källor för analytiker

Dhanuka Agritech Limited bevakas av 17 analytiker. 6 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.

AnalytikerInstitution
null null360 ONE Capital Market Private Limited
null nullAnand Rathi Shares and Stock Brokers Limited
Himanshu BinaniAnand Rathi Shares and Stock Brokers Limited